檢索結果 - Carol Addy

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies

    Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies 由 Melvin Khee‐Shing Leow, Carol Addy, Christos S. Mantzoros

    出版 2003
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active Antiretroviral Therapy

    Hypoadiponectinemia Is Associated with Insulin Resistance, Hypertriglyceridemia, and Fat Redistribution in Human Immunodeficiency Virus-Infected Patients Treated with Highly Active... 由 Carol Addy, Alina Gavrila, Sotirios Tsiodras, Kimberly G. Brodovicz, Adolf W. Karchmer, Christos S. Mantzoros

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece

    Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece 由 Eleni Petridou, Christos S. Mantzoros, Nick Dessypris, Panagiotis Koukoulomatis, Carol Addy, Zannis Voulgaris, George P. Chrousos, Dimitrios Trichopoulos

    出版 2003
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation

    Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation 由 Chai-Wan Kim, Carol Addy, Jun Kusunoki, Norma N. Anderson, Stanisław Deja, Xiaorong Fu, Shawn C. Burgess, Li Cai, Marcie Ruddy, Manu V. Chakravarthy, Steve Previs, Stuart Milstein, Kevin Fitzgerald, David E. Kelley, Jay D. Horton

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation

    Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation 由 Chai-Wan Kim, Carol Addy, Jun Kusunoki, Norma N. Anderson, Stanisław Deja, Xiaorong Fu, Shawn C. Burgess, Li Cai, Marcie Ruddy, Manu V. Chakravarthy, Steve Previs, Stuart Milstein, Kevin Fitzgerald, David E. Kelley, Jay D. Horton

    出版 2017
    獲取全文
    Errata/Corrigenda
    加到收藏夾
    Saved in:
  6. 6
    Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

    Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults 由 Ngozi Erondu, Ira Gantz, Bret J. Musser, Shailaja Suryawanshi, Madhuja Mallick, Carol Addy, Josée Côté, George A. Bray, Ken Fujioka, Harold Bays, Priscilla Hollander, Sandra Sanabria Bohórquez, Waisi Eng, Bengt Långström, Richard Hargreaves, H. Donald Burns, Akio Kanatani, Takehiro Fukami, Douglas J. MacNeil, Keith Gottesdiener, John M. Amatruda, Keith D. Kaufman, Steven B. Heymsfield

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    The effects of elafibranor in people with primary biliary cholangitis: a plain language summary

    The effects of elafibranor in people with primary biliary cholangitis: a plain language summary 由 Kris V. Kowdley, Christopher L. Bowlus, Cynthia Levy, Ulus Salih Akarca, Mário Reis Álvares‐da‐Silva, Pietro Andreoné, Marco Arrese, Sven Francque, Michael A. Heneghan, Pietro Invernizzi, D. I. Jones, Eric Lawitz, Marlyn J. Mayo, Mark G. Swain, Vı́ctor Vargas, John M. Vierling, Alejandra Villamil, Carol Addy, Julie Dietrich, Sarah Mazain, Bachirou Taddé, Benjamin F. Miller, Jianfen Shu, Claudia O. Zein, Carol L. Roberts, Gail E. Wright, Jörn M. Schattenberg

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake

    The Acyclic CB1R Inverse Agonist Taranabant Mediates Weight Loss by Increasing Energy Expenditure and Decreasing Caloric Intake 由 Carol Addy, Hamish Wright, Koen Van Laere, Ira Gantz, Ngozi Erondu, Bret J. Musser, Kaifeng Lu, Jinyu Yuan, Sandra Sanabria Bohórquez, Aubrey Stoch, Cathy Stevens, Tung M. Fong, Inge De Lepeleire, Caroline Cilissen, Josée Côté, Kim Rosko, Isaias Noel Gendrano, Allison Martin Nguyen, Barry Gumbiner, Paul Rothenberg, Jan de Hoon, Guy Bormans, Marleen Depré, Waisi Eng, Éric Ravussin, Samuel Klein, John E. Blundell, Gary Herman, H. Donald Burns, Richard Hargreaves, John A. Wagner, Keith Gottesdiener, John M. Amatruda, Steven B. Heymsfield

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: